Please use this identifier to cite or link to this item:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7872
Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017-2019 and 2020 | |
Daniel Ramírez García Omar Yaxmehen Bello-Chavolla Neftali Eduardo Antonio Villa Luisa Fernández Chirino Carlos Fermín Martínez Arsenio Vargas Vázquez Martín Roberto Basile Alvarez Ana Elena Hoyos-Lázaro Rodrigo M. Carrillo-Larco Jacqueline Seiglie Jennifer Manne-Goehler Deborah Wexler | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
https://doi.org/10.1101/2022.02.24.22271337 | |
ACKGROUND Excess all-cause mortality rates in Mexico in 2020 during the COVID-19 pandemic were among the highest globally. Recent reports suggest that diabetes-related deaths were also higher, but the contribution of diabetes as a cause of excess mortality in Mexico during 2020 compared to prior years has not yet been characterized. METHODS We conducted a retrospective, state-level study using national death registries from Mexican adults ≥20 years for the 2017-2020 period. Diabetes-related deaths were classified using ICD-10 codes that listed diabetes as the primary cause of death, excluding certificates which listed COVID-19 as a cause of death. Excess mortality was estimated as the increase in diabetes-related mortality in 2020 compared to average rates in 2017-2019. Analyses were stratified by diabetes type, diabetes-related complication, and in-hospital vs. out-of-hospital death. We evaluated the geographic distribution of diabetes-related excess mortality and its socio-demographic and epidemiologic correlates using spatial analyses and negative binomial regression models. RESULTS We identified 148,437 diabetes-related deaths in 2020 (177/100,000 inhabitants), 41.6% higher than the average for 2017-2019, with the excess occurring after the onset of the COVID-19 pandemic. In-hospital diabetes-related deaths decreased by 17.8% in 2020 compared to 2017-2019, whereas out-of-hospital deaths increased by 89.4%. Most deaths were attributable to type 2 diabetes and type 1 diabetes (129.7 and 4.0/100,000 population). Diabetes-related emergencies as contributing causes of death also increased in 2020 compared to 2017-2019 for hyperglycemic hyperosmolar state (128%), and ketoacidosis (116%). Diabetes-related excess mortality clustered in southern Mexico and was highest in states with higher social lag, higher rates of COVID-19 hospitalization, and higher prevalence of HbA1c ≥7.5%. INTERPRETATION Diabetes-related mortality increased among Mexican adults by 41.6% in 2020 after the onset of the pandemic compared to 2017-2019, largely attributable to type 2 diabetes. Excess diabetes-related deaths occurred disproportionately out-of-hospital, clustered in southern Mexico, and were associated with higher state-level marginalization, rates of COVID-19 hospitalizations, and higher prevalence of suboptimal glycemic control. Urgent policies to mitigate mortality due to diabetes in Mexico are needed, particularly given the ongoing challenges in caring for people with di | |
Medrxiv | |
25-02-2022 | |
Preimpreso | |
medrxiv.org/ | |
VIRUS RESPIRATORIOS | |
Appears in Collections: | Artículos científicos |
Upload archives
File | Size | Format | |
---|---|---|---|
Diabetes-related excess mortality in Mexico a comparative analysis of national death registries between 2017-2019 and 2020.pdf | 389.61 kB | Adobe PDF | View/Open |